PrEP Truvada Oral denied for failing step therapy by Cigna?
Step-therapy denials usually flip when the appeal documents that prior alternatives were tried and failed, or were contraindicated, or aren't safe for the patient.
US health-plan appeal rights
Cite: Most US health plans have appeal rights under either the ACA, ERISA, or Medicare/Medicaid rules
Most US health plans are required by federal law to give you both an internal appeal (where the insurer reconsiders) and an external review (where an independent reviewer decides). The exact timelines and processes depend on what kind of plan you have — marketplace / employer group, self-funded, Medicare Advantage, or Medicaid MCO — but in every case there's a window after the denial during which you have the right to fight it.
What Cigna typically requires
Cigna's specific coverage criteria for prep truvada oral are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.
The Cigna angle on PrEP Truvada Oral
## Why Cigna Denied PrEP (Truvada) Under Step Therapy
A step-therapy (also called "fail-first") denial means Cigna requires you to try and document failure on a preferred PrEP agent before it will authorize oral Truvada. For HIV pre-exposure prophylaxis, step-therapy policies have come under increasing legal and regulatory scrutiny because a "failure" of HIV prevention — unlike a failure of, say, a cholesterol medication — can have irreversible health consequences. Many states have enacted step-therapy reform laws that require insurers to grant exceptions when clinical circumstances warrant it.
## Why This Denial Is Appealable
Step-therapy denials are appealable on two independent grounds. First, if your prescriber has a clinical reason for selecting oral Truvada specifically — including but not limited to tolerability, renal or bone considerations documented in your chart, or prior experience with the preferred agent — that constitutes grounds for a step-therapy exception under both Cigna's own policy and, in many states, state law. Second, for non-grandfathered plans, a step-therapy requirement that delays access to a USPSTF Grade A preventive service may independently violate the ACA's preventive-services coverage mandate.
## Federal Appeal Framework
- Step-therapy exception request: File this first and simultaneously with the formal appeal. Your prescriber must document the clinical rationale for skipping the preferred agent.
- Internal appeal (ACA §2719 / ERISA §503): You have the right to a full-and-fair internal review of the step-therapy determination. The denial letter states the deadline.
- External review: If the internal appeal fails, you may request independent IRO review at no cost, generally within four months of the final denial. Expedited review (72 hours) is available when delay would seriously jeopardize your health.
- State step-therapy reform laws: Many states (including NY, TX, and others) have enacted laws with mandatory exception criteria for step-therapy denials. Check your state's law — it may provide faster relief than the federal process.
## Concrete Appeal Process and Timeline
1. Identify which preferred PrEP agent(s) Cigna requires you to try first. 2. Have your prescriber document in the chart why oral Truvada is the clinically appropriate choice for you and why the required first-step agent is not. 3. Submit a step-therapy exception request and formal internal appeal simultaneously. 4. If denied, escalate to external IRO review within the stated window.
## Documentation to Gather
- Clinical rationale for oral Truvada: Prescriber notes and letter explaining why this specific agent is appropriate for you — addressing any renal history, bone health history, comorbidities, or prior medication experience relevant to the prescribing choice.
- Assessment of required first-step agent: Documentation of why the preferred agent is not appropriate (prior adverse experience, contraindication per prescriber judgment, or other clinical factor). Note: your prescriber must make this clinical determination; it should be grounded in your chart.
- HIV-negative status and PrEP candidacy: Current labs and risk-factor documentation.
- State law citation (if applicable): A reference to your state's step-therapy reform statute, if one exists, and its mandatory exception criteria.
## Criteria-Mapping Structure
For each step-therapy exception criterion in Cigna's policy (and your state's law, if applicable):
| Step-Therapy Exception Criterion | Clinical Evidence Meeting It | |---|---| | [Copy exact language from Cigna policy or state law] | [Specific chart note, prior Rx history, or prescriber statement] |
A prescriber-signed exception request that maps directly to each criterion is the most effective instrument for overturning a step-therapy denial without requiring you to try a medication your doctor considers clinically inappropriate.
Next steps
- Find the date on the denial letter — your appeal window starts there.
- Read your plan's Summary of Benefits and Coverage (SBC) for the specific deadlines.
- Request the insurer's claim file in writing — they must provide it.
- Submit your appeal in writing with new clinical evidence and a physician statement.
Get the letter drafted
DenialHelp drafts your appeal in 5 minutes — $40 list price, $30 for your first letter (use code SEO25). We cite the federal regs and the specific clinical evidence your plan responds to. Your physician signs and sends.
Start my appeal — $30 with code SEO25 →